Skip to main content
Have a personal or library account? Click to login
Expression of NF-κB p65 phosphorylated at serine-536 in rectal cancer with or without preoperative radiotherapy Cover

Expression of NF-κB p65 phosphorylated at serine-536 in rectal cancer with or without preoperative radiotherapy

Open Access
|Sep 2011

References

  1. Hanahan D, Weinberg RA. The hallmarks of cancer.2000;: 57-70.
  2. Moynagh PN. The NF-kappaB pathway.2005;: 4589-92.
  3. Sun XF, Zhang H. NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases.2007;: 1387-98.
  4. Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain.1999;: 30353-6.
  5. Viatour P, Merville MP, Bours V, Chariot Al. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.2005;: 43-52.
  6. Miyakoshi J, Yagi K, Inhibition of IκB-α phosphorylation at serine and tyrosine acts independently on sensitization to DNA damaging agents in human glioma cells.2000;: 28-33.
  7. Yamagashi N, Miyakoshi J, Takebe H. Enhanced radiosensitivity by inhibition of nuclear factor kappa B activation in human malignant glioma cells.1997;: 157-62.
  8. Velenik V, Oblak I; Anderluh F. Quality of life in patients after combined modality treatment of rectal cancer: Report of a prospective phase II study.2008;: 207-14.
  9. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial.1997;: 980-7.
  10. Velenik V. Locally recurrent rectal cancer: treatment options.2009;: 144-51.
  11. Loftås P, Önnesjö S, Widegren E, Adell G, Kayed H, Kleeff J, et al. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.2009;: 137-42.
  12. Pfeifer D, Gao J, Adell G, Sun X-F. Expression of the p73 protein in rectal cancers with or without preoperative radiotherapy.2006;: 1143-8.
  13. Wallin Å, Svanvik J, Adell G, Sun X-F. Expression of PRL proteins at invasive margin of rectal cancers in relation to preoperative radiotherapy.2006;: 452-8.
  14. Zhang ZY, Zhao ZR, Adell G, Jarlstelt I, Cul YX, Kayed H, et al. MAC30 in rectal cancers with or without preoperative radiotherapy.2006;: 259-65.
  15. Lind DS, Hochwald SN, Malaty J, Rekkas S, Hebig P, Mishra G, et al. Nuclear factor-κB is upregulated in colorectal cancer.2001;: 363-9.
  16. Yu HG, Yu LL, Yang Y, LuoH-S, Yu J-P, MeierJJ, et al. Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis.2003;: 37-45.
  17. Christian S, Winkler R, Helfrich I, Boos AM, Besemfelder E, Schadendorf D, et al. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells.2008;: 486-94.
  18. MacFadyen J, Savage K, Wienke D, Isacke CM. Endosialin is expressed on stromal fibroblasts and CNS pericytes in mouse embryos and is downregulated during development.2007;: 363-69.
  19. Tomkowicz B, Rybinski K, Foley B, Ebel W, Kline B, Routhier E, et al. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration.2007;: 17965-70.
  20. Morrison BW, Moorman JR, Kowdley GC, Kobayashi YM, Jones LR, Leder P. Mat-8, a novel phospholemman-like protein expressed in human breast tumors, induces a chloride conductance in Xenopus oocytes.1995;: 2176-82.
  21. Kayed H, Kleeff J, Kolb A, Ketterer K, Keleg S, Felix K, et al. FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth.2006;: 43-54.
  22. Ocvirk J. Advances in the treatment of metastatic colorectal carcinoma.2009;: 1-8.
  23. Bardelli A, Saha S, Sager JA, Romans KE, Xin B, Markowitz SD,PRL-3 expression in metastatic cancers.2003;:5607-15.
  24. Sager JA, Benvenuti S, Bardelli A: PRL-3: a phosphatase for metastasis?2004;:952-3.
  25. Bénard J, Douc-Rasy S, Ahomadegbe JC. TP53 family members and human cancers.2003;:182-91.
  26. Sun XF. p73 overexpression is a prognostic factor in patients with colorectal adenocarcinoma.2002;:165-70.
  27. Malhotra K, Luehrsen KR, Costello LL, Raich TJ, Sim K, Foltz L,Identification of differentially expressed mRNAs in human fetal liver across gestation.1999;:839-47.
  28. Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. Identification and characterization of genes differentially expressed in meningiomas.1993;:715-22.
  29. Moparthi S, Arbman G, Wallin Å, Kayed H, Kleeff J, Zentgraf H,Expression of MAC30 protein is related to survival and biological variables in primary and metastatic colorectal cancers.2007;:91-5.
  30. Kayed H, Kleeff J, Ding J, Hammer J, Giese T, Zentgraf H,Expression analysis of MAC30 in human pancreatic cancer and tumors of the gastrointestinal tract.2004;:1021-31.
DOI: https://doi.org/10.2478/v10019-011-0030-7 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 279 - 284
Published on: Sep 22, 2011
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2011 Andreas Lewander, Jinfang Gao, Gunnar Adell, Hong Zhang, Xiao-Feng Sun, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.